• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IGHV 未突变的 CLL B 细胞比突变的 CLL B 细胞更容易发生自发性凋亡,并受到环境的生存促进信号的影响。

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.

机构信息

Divisione di Ematologia dell'Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Torino, Italy.

出版信息

Leukemia. 2011 May;25(5):828-37. doi: 10.1038/leu.2011.12. Epub 2011 Mar 4.

DOI:10.1038/leu.2011.12
PMID:21372840
Abstract

Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.

摘要

慢性淋巴细胞白血病 (CLL) 中的肿瘤细胞在体外培养时更容易发生凋亡,因为它们缺乏体内通过 B 细胞受体 (BCR) 依赖性和非依赖性途径提供的生存信号。本研究比较了未突变 (UM) 和突变 (M) CLL B 细胞对自发凋亡和生存信号的敏感性。UM CLL B 细胞的自发凋亡率明显高于 M CLL B 细胞。核因子-kB (NF-kB) 迅速失活,B 细胞白血病/淋巴瘤 2 (Bcl-2) 表达逐渐下调。CD40-Ligand、白细胞介素-4 和基质细胞显著提高了它们的存活率,并部分恢复了 Bcl-2,但未恢复 NF-kB 表达。外周血单核细胞也为 UM CLL B 细胞提供了保护,并恢复了 NF-kB 和 Bcl-2 的表达。通过细胞间接触和可溶性因子,T 细胞而非护理样细胞负责保护 UM CLL B 细胞。尽管具有更具侵袭性的特征,但 UM CLL B 细胞更容易发生自发凋亡,并依赖环境生存信号。UM CLL B 细胞的这种脆弱性可被用作治疗干预的选择性靶标。

相似文献

1
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.IGHV 未突变的 CLL B 细胞比突变的 CLL B 细胞更容易发生自发性凋亡,并受到环境的生存促进信号的影响。
Leukemia. 2011 May;25(5):828-37. doi: 10.1038/leu.2011.12. Epub 2011 Mar 4.
2
Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.在 CD40/TLR9 触发后,IgH 突变与未突变 CLL 细胞中 NF-κB 信号和化疗耐药性的二分法。
Oncogene. 2010 Sep 9;29(36):5071-82. doi: 10.1038/onc.2010.248. Epub 2010 Jun 28.
3
Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.丙戊酸通过激活死亡受体途径诱导慢性淋巴细胞白血病细胞凋亡,并增强肿瘤坏死因子相关凋亡诱导配体(TRAIL)反应。
Exp Hematol. 2007 Oct;35(10):1527-37. doi: 10.1016/j.exphem.2007.06.014. Epub 2007 Aug 13.
4
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.具有定型B细胞受体的慢性淋巴细胞白血病的分子和临床特征:一项意大利多中心研究的结果
Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19.
5
A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.PI3K/NF-κB信号通路的持续激活对慢性淋巴细胞白血病B细胞的存活至关重要。
Leukemia. 2004 Aug;18(8):1391-400. doi: 10.1038/sj.leu.2403398.
6
Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.IgG 阳性慢性淋巴细胞白血病中 B 细胞受体的结构和功能特征
Clin Cancer Res. 2006 Mar 15;12(6):1672-9. doi: 10.1158/1078-0432.CCR-05-2164.
7
Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.ZAP70 在慢性淋巴细胞白血病中的表达激活 NF-κB 信号通路。
Br J Haematol. 2013 Dec;163(5):621-30. doi: 10.1111/bjh.12588. Epub 2013 Oct 8.
8
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.里氏转化的免疫球蛋白重链可变区(IgVH)突变状态及克隆性分析:弥漫性大B细胞淋巴瘤和霍奇金淋巴瘤合并B细胞慢性淋巴细胞白血病(B-CLL)代表了两种不同的疾病演变途径。
Am J Surg Pathol. 2007 Oct;31(10):1605-14. doi: 10.1097/PAS.0b013e31804bdaf8.
9
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.定型亚群 #1 慢性淋巴细胞白血病:B 细胞受体结构、功能与患者预后之间的直接联系。
Am J Hematol. 2014 Jan;89(1):74-82. doi: 10.1002/ajh.23591.
10
Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells.辛伐他汀及下游抑制剂可克服IGHV未突变的慢性淋巴细胞白血病(CLL)细胞对阿霉素的固有及基质细胞诱导的耐药性。
Oncotarget. 2015 Oct 6;6(30):29833-46. doi: 10.18632/oncotarget.4006.

引用本文的文献

1
Tumor Cell Survival Factors and Angiogenesis in Chronic Lymphocytic Leukemia: How Hot Is the Link?慢性淋巴细胞白血病中的肿瘤细胞存活因子与血管生成:二者关联有多紧密?
Cancers (Basel). 2024 Dec 29;17(1):72. doi: 10.3390/cancers17010072.
2
Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era.个性化医疗时代慢性淋巴细胞白血病的治疗
Pharmaceutics. 2023 Dec 29;16(1):55. doi: 10.3390/pharmaceutics16010055.
3
Expression and Activity of the NF-κB Subunits in Chronic Lymphocytic Leukaemia: A Role for RelB and Non-Canonical Signalling.
慢性淋巴细胞白血病中NF-κB亚基的表达与活性:RelB及非经典信号传导的作用
Cancers (Basel). 2023 Sep 26;15(19):4736. doi: 10.3390/cancers15194736.
4
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.塞利尼索联合抗肿瘤药物在慢性淋巴细胞白血病中的抗肿瘤活性。
Sci Rep. 2023 Oct 7;13(1):16950. doi: 10.1038/s41598-023-44039-0.
5
Assessment of Impact of Human Leukocyte Antigen-Type and Cytokine-Type Responses on Outcomes after Targeted Therapy Currently Used to Treat Chronic Lymphocytic Leukemia.评估人类白细胞抗原类型和细胞因子类型反应对目前用于治疗慢性淋巴细胞白血病的靶向治疗后结局的影响。
J Clin Med. 2023 Apr 6;12(7):2731. doi: 10.3390/jcm12072731.
6
In Vitro and In Vivo Models of CLL-T Cell Interactions: Implications for Drug Testing.慢性淋巴细胞白血病(CLL)-T细胞相互作用的体外和体内模型:对药物测试的意义。
Cancers (Basel). 2022 Jun 23;14(13):3087. doi: 10.3390/cancers14133087.
7
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL.靶向缺氧诱导因子-1α调控通路作为阻碍慢性淋巴细胞白血病肿瘤微环境相互作用的策略
Cancers (Basel). 2021 Jun 9;13(12):2883. doi: 10.3390/cancers13122883.
8
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.评估基于 SWATH-MS 的慢性淋巴细胞白血病细胞蛋白质组学分析中的技术和生物学变异性。
Sci Rep. 2021 Feb 3;11(1):2932. doi: 10.1038/s41598-021-82609-2.
9
Nurse-Like Cells and Chronic Lymphocytic Leukemia B Cells: A Mutualistic Crosstalk inside Tissue Microenvironments.类淋巴样细胞与慢性淋巴细胞白血病 B 细胞:组织微环境中的互惠交流。
Cells. 2021 Jan 22;10(2):217. doi: 10.3390/cells10020217.
10
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia.慢性淋巴细胞白血病样单克隆 B 细胞淋巴增生症表现出炎症特征增加,而在早期慢性淋巴细胞白血病中则减少。
Exp Hematol. 2021 Mar;95:68-80. doi: 10.1016/j.exphem.2020.12.007. Epub 2021 Jan 7.